CD69 and neoplasm: To determine whether the poor efficacy of CD3 mAb-expanded CTLs to reject the established tumor is due to induction of T cell anergy or senescence, CTLs were stained for cell surface expression levels of CD69 and CD25, two markers of T cell activation, at various time points after stimulation.